Literature DB >> 35300256

European Stroke Organisation - European Society for Minimally Invasive Neurological Therapy expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischaemic stroke and anterior circulation large vessel occlusion.

Guillaume Turc1, Georgios Tsivgoulis2,3, Heinrich J Audebert4, Hieronymus Boogaarts5, Pervinder Bhogal6, Gian Marco De Marchis7, Ana Catarina Fonseca8, Pooja Khatri9, Mikaël Mazighi10,11, Natalia Pérez de la Ossa12, Peter D Schellinger13, Daniel Strbian14, Danilo Toni15, Philip White16, William Whiteley17, Andrea Zini18, Wim van Zwam19, Jens Fiehler20.   

Abstract

Six randomized controlled clinical trials have assessed whether mechanical thrombectomy (MT) alone is non-inferior to intravenous thrombolysis (IVT) plus MT within 4.5 hours of symptom onset in patients with anterior circulation large vessel occlusion (LVO) ischaemic stroke and no contraindication to IVT. An expedited recommendation process was initiated by the European Stroke Organisation (ESO) and conducted with the European Society of Minimally Invasive Neurological Therapy (ESMINT) according to ESO standard operating procedure based on the GRADE system. We identified two relevant Population, Intervention, Comparator, Outcome (PICO) questions, performed systematic reviews and meta-analyses of the literature, assessed the quality of the available evidence and wrote evidence-based recommendations. Expert opinion was provided if insufficient evidence was available to provide recommendations based on the GRADE approach. For stroke patients with anterior circulation LVO directly admitted to a MT-capable centre ('mothership') within 4.5 hours of symptom onset and eligible for both treatments, we recommend IVT plus MT over MT alone (moderate evidence, strong recommendation). MT should not prevent the initiation of IVT, nor should IVT delay MT. In stroke patients with anterior circulation LVO admitted to a centre without MT facilities and eligible for IVT ≤4.5 hrs and MT, we recommend IVT followed by rapid transfer to a MT capable-centre ('drip-and-ship') in preference to omitting IVT (low evidence, strong recommendation). Expert consensus statements on ischaemic stroke on awakening from sleep are also provided. Patients with anterior circulation LVO stroke should receive IVT in addition to MT if they have no contraindications to either treatment. © European Stroke Organisation 2022.

Entities:  

Keywords:  endovascular therapy; ischaemic stroke; recommendations; thrombectomy; thrombolysis

Year:  2022        PMID: 35300256      PMCID: PMC8921785          DOI: 10.1177/23969873221076968

Source DB:  PubMed          Journal:  Eur Stroke J        ISSN: 2396-9873


  65 in total

1.  RoB 2: a revised tool for assessing risk of bias in randomised trials.

Authors:  Jonathan A C Sterne; Jelena Savović; Matthew J Page; Roy G Elbers; Natalie S Blencowe; Isabelle Boutron; Christopher J Cates; Hung-Yuan Cheng; Mark S Corbett; Sandra M Eldridge; Jonathan R Emberson; Miguel A Hernán; Sally Hopewell; Asbjørn Hróbjartsson; Daniela R Junqueira; Peter Jüni; Jamie J Kirkham; Toby Lasserson; Tianjing Li; Alexandra McAleenan; Barnaby C Reeves; Sasha Shepperd; Ian Shrier; Lesley A Stewart; Kate Tilling; Ian R White; Penny F Whiting; Julian P T Higgins
Journal:  BMJ       Date:  2019-08-28

2.  Extending the time window for intravenous thrombolysis in acute ischemic stroke using magnetic resonance imaging-based patient selection.

Authors:  Peter Ringleb; Martin Bendszus; Erich Bluhmki; Geoffrey Donnan; Christoph Eschenfelder; Marc Fatar; Christof Kessler; Carlos Molina; Didier Leys; Girish Muddegowda; Sven Poli; Peter Schellinger; Stefan Schwab; Joaquin Serena; Danilo Toni; Nils Wahlgren; Werner Hacke
Journal:  Int J Stroke       Date:  2019-04-04       Impact factor: 5.266

3.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

4.  Intravenous thrombolysis prior to mechanical thrombectomy in large vessel occlusions.

Authors:  Aristeidis H Katsanos; Konark Malhotra; Nitin Goyal; Adam Arthur; Peter D Schellinger; Martin Köhrmann; Christos Krogias; Guillaume Turc; Georgios Magoufis; Didier Leys; Niaz Ahmed; Pooja Khatri; Mayank Goyal; Andrei V Alexandrov; Georgios Tsivgoulis
Journal:  Ann Neurol       Date:  2019-07-22       Impact factor: 10.422

5.  Minimal Clinically Important Difference for Safe and Simple Novel Acute Ischemic Stroke Therapies.

Authors:  Jessica S Cranston; Brett D Kaplan; Jeffrey L Saver
Journal:  Stroke       Date:  2017-09-20       Impact factor: 7.914

6.  A Randomized Trial of Intravenous Alteplase before Endovascular Treatment for Stroke.

Authors:  Natalie E LeCouffe; Manon Kappelhof; Kilian M Treurniet; Leon A Rinkel; Agnetha E Bruggeman; Olvert A Berkhemer; Lennard Wolff; Henk van Voorst; Manon L Tolhuisen; Diederik W J Dippel; Aad van der Lugt; Adriaan C G M van Es; Jelis Boiten; Geert J Lycklama À Nijeholt; Koos Keizer; Rob A R Gons; Lonneke S F Yo; Robert J van Oostenbrugge; Wim H van Zwam; Bob Roozenbeek; H Bart van der Worp; Rob T H Lo; Ido R van den Wijngaard; Inger R de Ridder; Vincent Costalat; Caroline Arquizan; Robin Lemmens; Jelle Demeestere; Jeannette Hofmeijer; Jasper M Martens; Wouter J Schonewille; Jan-Albert Vos; Maarten Uyttenboogaart; Reinoud P H Bokkers; Julia H van Tuijl; Hans Kortman; Floris H B M Schreuder; Hieronymus D Boogaarts; Karlijn F de Laat; Lukas C van Dijk; Heleen M den Hertog; Boudewijn A A M van Hasselt; Paul J A M Brouwers; Tomas Bulut; Michel J M Remmers; Anouk van Norden; Farshad Imani; Anouk D Rozeman; Otto E H Elgersma; Philippe Desfontaines; Denis Brisbois; Yves Samson; Frédéric Clarençon; G Menno Krietemeijer; Alida A Postma; Pieter-Jan van Doormaal; René van den Berg; Anouk van der Hoorn; Ludo F M Beenen; Daan Nieboer; Hester F Lingsma; Bart J Emmer; Jonathan M Coutinho; Charles B L M Majoie; Yvo B W E M Roos
Journal:  N Engl J Med       Date:  2021-11-11       Impact factor: 91.245

Review 7.  Incidence and Predictors of Early Recanalization After Intravenous Thrombolysis: A Systematic Review and Meta-Analysis.

Authors:  Pierre Seners; Guillaume Turc; Benjamin Maïer; Jean-Louis Mas; Catherine Oppenheim; Jean-Claude Baron
Journal:  Stroke       Date:  2016-07-26       Impact factor: 7.914

8.  Access to and delivery of acute ischaemic stroke treatments: A survey of national scientific societies and stroke experts in 44 European countries.

Authors:  Diana Aguiar de Sousa; Rascha von Martial; Sònia Abilleira; Thomas Gattringer; Adam Kobayashi; Miquel Gallofré; Franz Fazekas; Istvan Szikora; Valery Feigin; Valeria Caso; Urs Fischer
Journal:  Eur Stroke J       Date:  2018-07-20

9.  Thrombolysis With Alteplase at 0.6 mg/kg for Stroke With Unknown Time of Onset: A Randomized Controlled Trial.

Authors:  Masatoshi Koga; Haruko Yamamoto; Manabu Inoue; Koko Asakura; Junya Aoki; Toshimitsu Hamasaki; Takao Kanzawa; Rei Kondo; Masafumi Ohtaki; Ryo Itabashi; Kenji Kamiyama; Toru Iwama; Taizen Nakase; Yusuke Yakushiji; Shuichi Igarashi; Yoshinari Nagakane; Shunya Takizawa; Yasushi Okada; Ryosuke Doijiri; Akira Tsujino; Yasuhiro Ito; Hideyuki Ohnishi; Takeshi Inoue; Yasushi Takagi; Yasuhiro Hasegawa; Yoshiaki Shiokawa; Nobuyuki Sakai; Masato Osaki; Yoshikazu Uesaka; Shinichi Yoshimura; Takao Urabe; Toshihiro Ueda; Masafumi Ihara; Takanari Kitazono; Makoto Sasaki; Akira Oita; Sohei Yoshimura; Mayumi Fukuda-Doi; Kaori Miwa; Kazumi Kimura; Kazuo Minematsu; Kazunori Toyoda
Journal:  Stroke       Date:  2020-04-06       Impact factor: 7.914

10.  Efficacy and safety of bridging thrombolysis initiated before transfer in a drip-and-ship stroke service.

Authors:  Jan Christoph Purrucker; Miriam Heyse; Simon Nagel; Christoph Gumbinger; Fatih Seker; Markus Möhlenbruch; Peter Arthur Ringleb
Journal:  Stroke Vasc Neurol       Date:  2021-07-26
View more
  1 in total

1.  Impact of Medical Community Model on Intravenous Alteplase Door-to-Needle Times and Prognosis of Patients With Acute Ischemic Stroke.

Authors:  Hongfei Li; Dongjuan Xu; Yunyun Xu; Lianyan Wei
Journal:  Front Surg       Date:  2022-04-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.